Do Clearside Biomedical Inc. (CLSD) beta value of 1.45 signposts another twist?

Let’s start up with the current stock price of Clearside Biomedical Inc. (CLSD), which is $3.95 to be very precise. The Stock rose vividly during the last session to $4.025 after opening rate of $3.61 while the lowest price it went was recorded $3.45 before closing at $3.60.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on January 12, 2021, Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD. Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the first patients have been enrolled in its Phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) in patients with neovascular age-related macular degeneration (wet AMD). Clinical sites, all based in the United States, are activated and currently screening wet AMD patients for this Phase 1/2a trial, known as OASIS, involving CLS-AX, a proprietary suspension of axitinib for suprachoroidal injection. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Clearside Biomedical Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.03 on 01/13/21, with the lowest value was $2.90 for the same time period, recorded on 01/04/21.

Clearside Biomedical Inc. (CLSD) full year performance was 64.58%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clearside Biomedical Inc. shares are logging -4.36% during the 52-week period from high price, and 259.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.10 and $4.13.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1510030 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Clearside Biomedical Inc. (CLSD) recorded performance in the market was 44.16%, having the revenues showcasing 165.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 198.17M, as it employees total of 33 workers.

Specialists analysis on Clearside Biomedical Inc. (CLSD)

During the last month, 3 analysts gave the Clearside Biomedical Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.85, with a change in the price was noted +2.13. In a similar fashion, Clearside Biomedical Inc. posted a movement of +117.03% for the period of last 100 days, recording 455,523 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CLSD is recording 0.12 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.05.

Trends and Technical analysis: Clearside Biomedical Inc. (CLSD)

Raw Stochastic average of Clearside Biomedical Inc. in the period of last 50 days is set at 97.28%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 96.44%. In the last 20 days, the company’s Stochastic %K was 89.62% and its Stochastic %D was recorded 85.60%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 44.16%. Additionally, trading for the stock in the period of the last six months notably improved by 111.23%, alongside a boost of 64.58% for the period of the last 12 months. The shares increased approximately by 14.49% in the 7-day charts and went down by 103.61% in the period of the last 30 days. Common stock shares were driven by 165.10% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here